GRACE :: Lung Cancer

Search cancerGRACE.org

Dr West

Defining Bronchioloalveolar Carcinoma (BAC): One End of a Spectrum

Share
download as a pdf file Download PDF of this page

The clinical syndrome of BAC is characterized by spread primarily through the lungs, a higher proportion of never-smokers or light former smokers, a greater proportion of women, and often progresses more slowly than most other lung cancers. This clinical and radiographic (scans) scenario isn’t necessarily seen only with “pure BAC” under the microscrope from a biopsy, but rather can be a spectrum from pure BAC to part non-invasive BAC pattern and part invasive adenocarcinoma, and on the other end of the continuum is invasive adenocarcinoma, as shown in the illustration of how these appear under a microscope.

Pure BAC Adenocarcinoma w/BAC Features Invasive Adenocarcinoma
Pure BAC Adeno w/BAC Features Invasive Adeno


It doesn’t have to be “pure BAC” to behave like a BAC clinical picture. The variability in how BAC behaves is still poorly understood. Overall, invasive adenocarcinoma (without BAC) has a worse prognosis than adeno/BAC mix, but there’s tons we don’t know yet. Importantly, many of the amazing responders with what is called BAC actually have adenocarcinoma with BAC characteristics under the microscope. And the response rate on BAC trials of drugs like Iressa (gefitinib) and Tarceva (erlotinib) actually suggest that patients with adenocarcinoma with BAC characteristics may do better than pure BAC. One of the other complications is that there are two different types of pure BAC, mucinous and nonmucinous. In the BAC trial with Iressa, which I led and published recently, patients with mucinous pure BAC did very poorly, while those with the non-mucinous type did considerably better. In any event, most current trials for “patients with BAC” allow patients with pure BAC or adeno with BAC to participate, and then the trial tries to collect tissue from the tumors to figure out patterns of which patients are getting a benefit and which are not. Right now, we really don’t know nearly enough about the different subtypes of BAC and how they will do with various treatments. But we’re getting better all the time.


4 Responses to Defining Bronchioloalveolar Carcinoma (BAC): One End of a Spectrum

  • Rodney says:

    How does one know if his BAC is mucinous or non-mucinous? This was never mentioned to me and I rarely see it defined anywhere although I have searched.

  • lodis says:

    It is can be usually found on a biopsy report such as Bronchoscope. Also it is a ask questiion for your onocolgist.
    Lodis

  • Kama says:

    What impact does smoking a pipe have on the prognosis and quality of life of a person with BAC? My father has been told (or he has interpreted) that quitting smoking may not make a difference.

  • Dr West
    Dr West says:

    On the question of BAC subtype, it is common to have information about mucinous vs. non-mucinous NOT included on a pathology report. If there is enough tissue (which may not be the cas, depending on what kind of biopsy was done), it may help to have tissue reviewed by a pathologist with an interest/expertise in lung cancer, often at larger cancer centers.
    With regard to the question on pipe smoking, this has definitely not been studied and likely will not have a major impact on the cancer either way, but his lung function from unaffected areas would be improved if he were to stop smoking. And with BAC you are often dealing with very limited lung capacity, so it helps to maximize what isn’t affected by BAC.

Leave a Reply

Ask Us, Q&A
Lung/Thoracic Cancer Expert Content

Archives

Share
download as a pdf file Download PDF of this page

GRACE Cancer Video Library - Lung Cancer Videos

 

2015_Immunotherapy_Forum_Videos

 

2015 Acquired Resistance in Lung Cancer Patient Forum Videos

Share
download as a pdf file Download PDF of this page

Join the GRACE Faculty

Breast Cancer Blog
Pancreatic Cancer Blog
Kidney Cancer Blog
Bladder Cancer Blog
Head/Neck Cancer Blog
Share
download as a pdf file Download PDF of this page

Subscribe to the GRACEcast Podcast on iTunes

Share
download as a pdf file Download PDF of this page

Email Newsletter icon, E-mail Newsletter icon, Email List icon, E-mail List icon

Subscribe to
GRACE Notes
   (Free Newsletter)

Other Resources

Share
download as a pdf file Download PDF of this page

ClinicalTrials.gov


Biomedical Learning Institute

peerview_institute_logo_243